BIIB's at a support level, but it's also been gapping up significantly every 2-6 quarters for the past few years. Its last gap was exactly a year ago, so it's overdue for a gap up. It's also within a month of earnings, so management is likely keen on pushing for newsworthy developments. I'll be rolling far OTM calls every week until earnings given the upside for...
Biogen Inc. (BIIB) currently testing channel support, able to absorb weekly selling pressures. From here, (BIIB) can recover and turn higher to channel resistance, eliciting gains of 20-25% over the following 2 - 3 months. A settlement above this week’s high would accelerate this upward momentum. Inversely, closing below this channel support would indicate...
Looking at the options chain today, i would buy the $255 calls with 2022-9-16 expiration date for about $3.40 premium. Looking forward to read your opinion about it.
I think it warrants making a new publication here, $BIIB has flashed a buy signal with tremendously good reward to risk, as it can resume the long term trend that can take it over $1600-2600 over time. Phase 3 clinical trials have gone really well for their Alzheimer's treatment 'Aduhelm', putting it in line with results obtained by $LLY's drug 'Donanemab'. I was...
Reward to risk long term in $BIIB is very attractive here. I've gone long via a calendar spread before the latest FDA approval news, which turned out like a good long position when Biogen's Alzheimer's drug Aduhelm received accelerated approval. Following this, related companies which also have Alzheimer's drugs pending approval (like $LLY) received a dramatic...
A staple of Cathie Wood's ARKK Invest fund, Teladoc looks to be winding up for a big move in the coming days after breaking the resistance of a supply line that has kept TDOC stagnant since the peak of its small rally in June. Now we find it at a key support level just outside of the trendline and finding support on our 21 MA as well. I am long on TDOC with a stop...
weekly based support and resistance analysis
Sell 50% of position at $350, 25% at $360, the remaining just let it fly.
BIIB has broken out of triangle triangle formation on strong signals from super guppy and MACD indicators. I expect this breakout to continue on both its solid technical's as well as the strong sentiment in regards to BIIB's potential ceiling. Two crucial stories to watch going forward are the potential appeals court reversal related to their multiple sclerosis...
Solid Biosciences Announces $90 Million Private Placement Solid Biosciences has entered into a securities purchase agreement with a select group of institutional investors and accredited investors for a $90 million private placement, which is expected to close on or about December 15, 2020, subject to the satisfaction of customary closing conditions. The private...
Biogen INC 22 June, we were monitoring this stock. Its been 1 month, we are still waiting for a good entry
I don't see any impulse patterns here. There is an Elliott triangle that just happened, but this is a part of a correction, hence bearish. Goaling for the floor first in blue, then the two fib targets after that if there is more gas for the downward move. NFA
Hey traders, I was searching for potential pivot points for long call opportunities and I came across Biogen NASDAQ:BIIB and thought to myself "Hey! This looks good!"... that is until I saw they're expected to report earnings tomorrow. But otherwise, take a look at the chart above. One thing you will see...is that its been trading within a range. I highlighted...
BIIB: Anticipated BIIB Elliot waves (daily chart)
My custom-coded indicators are pointing to a move higher in BIIB based on the latest weekly candlestick. The signal is weaker but still present and it appears to be bullish over the next few weeks.
BIIB closed the week around +25% as news regarding a crucial patent ruling came out in the company's favor. With the company's earnings also higher than the forecast, investors seem upbeat with the stock's dynamics. Even though the 1D chart turned overbought (RSI = 75.219, MACD = 6.690), on the weekly chart there is still a clear Resistance Zone at 370.00 - 389.00...